4th Quarter - Report

GENENTECH, INC for GENENTECH INC

Firm
Client
Income
—
Expenses
$610,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1548 - "Pathway for Biosimilars Act" H.R. 3962 - "Affordable health Care for America Act - Follow-on biologics provisions H.R. 3590 - "Patient Protection and Affordable Care Act"

LobbyistCovered position, as disclosed
DAVID B BURT —
STEPHANIE A DYSON New —
DARIN GARDNER New —
EVAN MORRIS New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1548 (111th), H.R. 3590 (111th), H.R. 3962 (111th)

Medicare/Medicaid MMM

H.R. 3962 - "Affordable health Care for American Act, opposition to Medicare rebates and coding and payment for follow-on biologics H.R. 3590 - "Patient Protection and Affordable Care Act", opposition to Medicare rebates

LobbyistCovered position, as disclosed
DAVID B BURT —
STEPHANIE A DYSON New —
DARIN GARDNER New —
EVAN MORRIS New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3590 (111th), H.R. 3962 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.